1. Spotlight from the American Society for Preventive Cardiology on Key Features of the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guidelines on the Management of Blood Cholesterol

   • Nathan D. Wong
   • Ezra A. Amsterdam
   • for the American Society for Preventive Cardiology

   Leading Article 08 July 2019 Pages: 1 - 9

   

2. High-Dose Omega-3 Fatty Acids in Cardiovascular Prevention: Finally Living Up to Their Potential?

   • Adam J. Nelson
   • Sam Mirzaee
   • Stephen J. Nicholls

   Current Opinion 04 September 2019 Pages: 11 - 18

   

3. Postoperative Atrial Fibrillation Following Cardiac Surgery: From Pathogenesis to Potential Therapies

   • Yousef Rezaei
   • Mohammad Mehdi Peighambari
   • Saeid Hosseini

   Review Article 10 September 2019 Pages: 19 - 49

   

4. Efficacy and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation Across BMI Categories: A Systematic Review and Meta-Analysis

   • Yue Zhou
   • Jianyong Ma
   • Wengen Zhu

   Systematic Review 24 July 2019 Pages: 51 - 60

   

5. Educational Impact on Apixaban Adherence in Atrial Fibrillation (the AEGEAN STUDY): A Randomized Clinical Trial

   • Gilles Montalescot
   • Carlos Brotons
   • the AEGEAN Study Investigators

   Original Research Article Open access 26 June 2019 Pages: 61 - 71

   

6. Effect of Spironolactone on Atrial Fibrillation in Patients with Heart Failure with Preserved Ejection Fraction: Post-Hoc Analysis of the Randomized, Placebo-Controlled TOPCAT Trial

   • Jolien Neefs
   • Nicoline W. E. van den Berg
   • Joris R. de Groot

   Original Research Article Open access 19 June 2019 Pages: 73 - 80

   

7. Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS

   • Patrick Blin
   • Caroline Dureau-Pournin
   • Nicholas Moore

   Original Research Article 29 June 2019 Pages: 81 - 103

   

8. Long-Term Quality of Prescription for ST-Segment Elevation Myocardial Infarction (STEMI) Patients: A Real World 1-Year Follow-Up Study

   • Christel Bruggmann
   • Juan F. Iglesias
   • Pierre Voirol

   Original Research Article Open access 12 July 2019 Pages: 105 - 115